Literature DB >> 2560684

Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects.

M D Littley1, S Gibson, A White, S M Shalet.   

Abstract

The glucagon stimulation test (GST) is often used to assess pituitary ACTH reserve, particularly when other tests are contra-indicated. In a preliminary investigation, in patients with pituitary disease, we failed to demonstrate the ACTH dependence of the cortisol response. We have therefore compared the ACTH, cortisol and glucose responses to glucagon (1 mg s.c.), insulin (0.2 U/kg i.v., ITT) and placebo in six healthy male volunteers, sampling every 10 min for 6 h. During the GST, mean +/- SD serum cortisol rose from 256 +/- 80 nmol/l to a peak of 481 +/- 164 nmol/l (range 289-717 nmol/l, P less than 0.01) in comparison with 280 +/- 81 nmol/l to 602 +/- 110 nmol/l (range 493-742 nmol/l) during the ITT (P less than 0.002). The mean peak cortisol levels achieved in the two tests did not differ significantly. In the GST, plasma ACTH rose from a mean basal value of 10.9 +/- 16.6 ng/l to a mean peak level of 123 +/- 76 ng/l (P less than 0.02) (ACTH ng/l x 0.225 = pmol/l). The corresponding values in the ITT were 7.1 +/- 16.2 ng/l and 263 +/- 91 ng/l (P less than 0.001). The mean peak ACTH level was significantly greater during the ITT (P less than 0.05). Thus the cortisol response was ACTH dependent in both the GST and the ITT in normal subjects. Furthermore, the ACTH response was of sufficient duration to be detected by the usual procedure of sampling every 30 min.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560684     DOI: 10.1111/j.1365-2265.1989.tb01276.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  An assessment of growth hormone provocation tests.

Authors:  P C Hindmarsh; P G Swift
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

2.  Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Authors:  Kevin C J Yuen; Beverly M K Biller; Laurence Katznelson; Sharon A Rhoads; Michelle H Gurel; Olivia Chu; Valentina Corazzini; Kellie Spiller; Murray B Gordon; Roberto Salvatori; David M Cook
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

3.  Effect of growth hormone replacement therapy on cognition after traumatic brain injury.

Authors:  Walter M High; Maria Briones-Galang; Jessica A Clark; Charles Gilkison; Kurt A Mossberg; Dennis J Zgaljardic; Brent E Masel; Randall J Urban
Journal:  J Neurotrauma       Date:  2010-09       Impact factor: 5.269

4.  Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Authors:  Amir H Hamrahian; Kevin C J Yuen; Murray B Gordon; Karen J Pulaski-Liebert; James Bena; Beverly M K Biller
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

Review 5.  Aetiology, diagnosis, and management of hypopituitarism in adult life.

Authors:  V K B Prabhakar; S M Shalet
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

6.  The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults.

Authors:  Zuleyha Karaca; Ayhan Lale; Fatih Tanriverdi; Mustafa Kula; Kursad Unluhizarci; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

7.  Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease.

Authors:  Valentina Gasco; Alessandro Berton; Mirko Parasiliti Caprino; Ioannis Karamouzis; Mauro Maccario; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2014-12-09       Impact factor: 3.633

8.  Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.

Authors:  Kevin C J Yuen
Journal:  ISRN Endocrinol       Date:  2011-08-11

Review 9.  How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism?

Authors:  Aoife Garrahy; Amar Agha
Journal:  BMC Endocr Disord       Date:  2016-06-17       Impact factor: 2.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.